Correlation Between VMware and Ligand Pharms

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VMware and Ligand Pharms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VMware and Ligand Pharms into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VMware Inc and Ligand Pharms Glucagon, you can compare the effects of market volatilities on VMware and Ligand Pharms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VMware with a short position of Ligand Pharms. Check out your portfolio center. Please also check ongoing floating volatility patterns of VMware and Ligand Pharms.

Diversification Opportunities for VMware and Ligand Pharms

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between VMware and Ligand is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding VMware Inc and Ligand Pharms Glucagon in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ligand Pharms Glucagon and VMware is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VMware Inc are associated (or correlated) with Ligand Pharms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ligand Pharms Glucagon has no effect on the direction of VMware i.e., VMware and Ligand Pharms go up and down completely randomly.

Pair Corralation between VMware and Ligand Pharms

If you would invest  0.19  in Ligand Pharms Glucagon on January 26, 2024 and sell it today you would earn a total of  0.11  from holding Ligand Pharms Glucagon or generate 57.89% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy50.0%
ValuesDaily Returns

VMware Inc  vs.  Ligand Pharms Glucagon

 Performance 
       Timeline  
VMware Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VMware Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable primary indicators, VMware is not utilizing all of its potentials. The current stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Ligand Pharms Glucagon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Ligand Pharms Glucagon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak basic indicators, Ligand Pharms showed solid returns over the last few months and may actually be approaching a breakup point.

VMware and Ligand Pharms Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VMware and Ligand Pharms

The main advantage of trading using opposite VMware and Ligand Pharms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VMware position performs unexpectedly, Ligand Pharms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ligand Pharms will offset losses from the drop in Ligand Pharms' long position.
The idea behind VMware Inc and Ligand Pharms Glucagon pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings